(HealthDay News) -- Here are the latest clinical trials,
This study is for people with chronic hepatitis C, genotype 1.
You must have had a liver biopsy less than 24 months ago without
evidence of cirrhosis to qualify.
The research site is in Tamarac, Fla.
This study will evaluate the cardiovascular safety of febuxostat
and allopurinol in people with gout and cardiovascular disease.
Participants receive study medication and related medical care at
no cost, and compensation for time and travel.
The research site is in Houston, Texas.
This study will evaluate the safety and tolerability of an
investigational drug for moderate-to-severe chronic plaque
The research site is in Winston-Salem, N.C.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.